Odontoprev S.A. (ODPV3.SA)
- Previous Close
11.21 - Open
0.00 - Bid 11.02 x --
- Ask 11.38 x --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 12.47 - Volume
0 - Avg. Volume
1,655,024 - Market Cap (intraday)
6.121B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
10.90 - EPS (TTM)
1.03 - Earnings Date Aug 6, 2025
- Forward Dividend & Yield 1.04 (9.24%)
- Ex-Dividend Date May 12, 2025
- 1y Target Est
11.85
Odontoprev S.A. provides private dental plans in Brazil. It operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; retails and wholesales sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of warehousing, storage, loading, organization, custody of goods, technical, and administrative programming services, as well as general management of goods and business. In addition, the company engages in collecting, sending, or delivering mail, documents, and objects or goods; integrating technologies to develop dental solutions; and provision of specialized services related to accidents and diseases, besides actuarial, financial, administrative, and commercial and risk management services. Odontoprev S.A. was founded in 1987 and is headquartered in Barueri, Brazil. Odontoprev S.A. operates as a subsidiary of Bradesco Saúde S.A.
www.odontoprev.com.brRecent News: ODPV3.SA
View MorePerformance Overview: ODPV3.SA
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ODPV3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ODPV3.SA
View MoreValuation Measures
Market Cap
6.12B
Enterprise Value
5.65B
Trailing P/E
10.89
Forward P/E
11.10
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.64
Price/Book (mrq)
4.49
Enterprise Value/Revenue
2.44
Enterprise Value/EBITDA
5.08
Financial Highlights
Profitability and Income Statement
Profit Margin
22.87%
Return on Assets (ttm)
23.43%
Return on Equity (ttm)
39.44%
Revenue (ttm)
2.46B
Net Income Avi to Common (ttm)
562.23M
Diluted EPS (ttm)
1.03
Balance Sheet and Cash Flow
Total Cash (mrq)
459.63M
Total Debt/Equity (mrq)
1.89%
Levered Free Cash Flow (ttm)
534.97M